CLINICAL SUPPLY MANAGEMENT ARTICLES
The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
Early-stage biotechs often overbuild systems too soon. Alicia Collins explains why flexibility, simple processes, and realistic assumptions matter most.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
Reliable clinical supply requires proper vendor selection, cross-functional communication, and safety nets built to accommodate an ever-changing geopolitical and global pharmaceutical landscape. To avoid supply disruptions for clinical drugs, sponsors must give clinical supply its proper weight in initial protocol development and trial design.
-
Consider how integrated response technologies and electronic clinical outcomes assessments can improve configurability, study start-up, and flexible mid-study changes.
-
Many organizations struggle with siloed operations, but this modern GxP inventory solution solves these challenges by providing a centralized, cloud-based platform for end-to-end visibility.
-
Preparing for a regulatory inspection during a clinical trial can be daunting. Learn about the importance of clear roles, audit trails, data integrity, and training, and get recommendations to help.
-
How can investing in suitable tech solutions enhance efficiency and reduce companies' carbon footprint?
-
When selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.